We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

93 hedge funds and large institutions have $389M invested in Global Blood Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 11

180% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 10

69% more capital invested

Capital invested by funds: $229M → $389M (+$159M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

42% more call options, than puts

Call options by funds: $2.21M | Put options by funds: $1.55M

24% more funds holding

Funds holding: 75 → 93 (+18)

Holders
93
Holders Change
+18
Holders Change %
+24%
% of All Funds
2.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
28
Increased
48
Reduced
11
Closed
10
Calls
$2.21M
Puts
$1.55M
Net Calls
+$656K
Net Calls Change
-$17M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$24.2M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$19.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.4M
4
PA
Perceptive Advisors
New York
+$18.4M
5
ACA
Avoro Capital Advisors
New York
+$15.2M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$9.52M
2
RI
RTW Investments
New York
-$1.89M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.78M
4
Goldman Sachs
Goldman Sachs
New York
-$1.22M
5
DA
DSC Advisors
Illinois
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
26
BlackRock Institutional Trust
California
$2.36M +$1.35M +67,040 +89%
Asset Management One
27
Asset Management One
Japan
$2.31M +$1.08M +53,532 +60%
Millennium Management
28
Millennium Management
New York
$2.23M +$2.71M +134,115 New
UBS Group
29
UBS Group
Switzerland
$2.14M -$68.5K -3,396 -3%
AG
30
Artal Group
Luxembourg
$2.07M +$2.52M +125,000 New
TCM
31
Tekla Capital Management
Massachusetts
$2.07M +$2.52M +125,000 New
LCM
32
Laurion Capital Management
New York
$1.74M +$2.12M +105,000 New
FMA
33
FNY Managed Accounts
New York
$1.67M +$2.03M +100,700 New
RSCM
34
Rock Springs Capital Management
Maryland
$1.63M +$403K +20,000 +26%
RI
35
RTW Investments
New York
$1.61M -$1.89M -93,843 -49%
HCMT
36
Highland Capital Management (Texas)
Texas
$1.36M +$1.66M +82,200 New
SSA
37
Schonfeld Strategic Advisors
New York
$1.29M +$1.57M +77,912 New
VM
38
VHCP Management
New York
$1.21M – – –
Morgan Stanley
39
Morgan Stanley
New York
$1.21M +$718K +35,593 +95%
BIM
40
BlackRock Investment Management
Delaware
$1.17M +$938K +46,486 +195%
Goldman Sachs
41
Goldman Sachs
New York
$1.14M -$1.22M -60,330 -47%
LP
42
LMR Partners
United Kingdom
$1.05M +$1.28M +63,531 New
ARTA
43
A.R.T. Advisors
New York
$1.05M +$137K +6,780 +12%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$1.04M +$187K +9,282 +17%
JGC
45
J. Goldman & Co
New York
$1.03M +$1.25M +62,100 New
Norges Bank
46
Norges Bank
Norway
$995K +$1.21M +60,000 New
Thrivent Financial for Lutherans
47
Thrivent Financial for Lutherans
Minnesota
$854K +$1.04M +51,470 New
UOC
48
UBS O'Connor
Illinois
$830K +$1.01M +50,000 New
BlackRock
49
BlackRock
New York
$812K +$980K +48,579 +12,618%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$805K +$978K +48,495 New
1
2
3 4 5

GBT Hedge Fund Activity: Q2 2016 in Review

93 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q2 2016, worth a combined $389M — up 69% from $229M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new GBT positions and 10 closed out — a net gain of 18 holders — while 48 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $24.2M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $9.52M sold.

  • 93 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q2 2016, up from 75 in Q1 2016.
  • Funds reported $389M of Global Blood Therapeutics, Inc. stock for Q2 2016, up 69% quarter-over-quarter.
  • 28 funds opened new Global Blood Therapeutics, Inc. positions in Q2 2016 and 10 closed out, a net change of +18 holders.
  • The largest Global Blood Therapeutics, Inc. buyer in Q2 2016 was Wellington Management Group, an estimated $24.2M added.
  • The largest Global Blood Therapeutics, Inc. seller in Q2 2016 was Baker Bros. Advisors, an estimated $9.52M sold.

Based on aggregated 13F filings for Q2 2016.